immunotherapy

2022 ASCO Annual Meeting; #ASCO22
September 15, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma. Read More >>
June 15, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning. Read More >>
ASCO ® Plenary Series
April 18, 2022 · Greg Guthrie, ASCO staff
Read research from the April 2022 session of the ASCO Plenary Series, which highlights a clinical trial that studied a medication called tislelizumab combined with chemotherapy to treat recurrent or metastatic nasopharyngeal cancer. Read More >>
ASCO ® Plenary Series
March 14, 2022 · Brielle Gregory Collins, ASCO staff
Read research from the March 2022 session of the ASCO Plenary Series, which highlights an immunotherapy combination to treat advanced melanoma and adding immunotherapy to chemotherapy to treat advanced non-small cell lung cancer. Read More >>
February 3, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Christopher Flowers discusses research from the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, including studies evaluating new treatments for diffuse large B-cell lymphoma and an overview of a session on improving equity in cancer clinical trials. Read More >>

Pages